From: Hodgkin Lymphoma Treatment (PDQ®)
PDQ Cancer Information Summaries [Internet].
Bethesda (MD): National Cancer Institute (US); 2002-.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Table 4. Chemotherapy Regimens Used to Treat Hodgkin Lymphoma
| Combination Name | Drugs Included | Prognostic Group |
|---|---|---|
| ABVD | Doxorubicin, bleomycin, vinblastine, and dacarbazine | Early favorable classic |
| Early unfavorable classic | ||
| AVD | Doxorubicin, vinblastine, and dacarbazine | Early favorable classic |
| Advanced classic | ||
| BEACOPP | Bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone | Early unfavorable classic |
| Advanced classic | ||
| GVD | Gemcitabine, vinorelbine, and liposomal doxorubicin | Recurrent classic |
| ICE | Ifosfamide, carboplatin, and etoposide | Recurrent classic |
| MOPP | Mechlorethamine, vincristine, procarbazine, and prednisone | Advanced classic |